N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine

C168H133N9O7 — CID 157150600

IUPACN,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine
SMILESC(=Cc1nc2cc(-c3ccccc3)ccc2o1)c1ccc(N(c2ccccc2)c2cc3ccccc3c3ccccc23)cc1.C(=Cc1nc2ccc(-c3ccccc3)cc2o1)c1ccc(N(c2ccccc2)c2ccccc2)cc1.CC=Cc1nc2cc(C)ccc2o1.CC=Cc1nc2cc(C)ccc2o1.COc1cc(/C=C/c2nc3ccc(-c4ccc(-c5ccc(-c6ccc(C)cc6)cc5)cc4)cc3o2)c(C)cc1C.Cc1ccc(-c2ccc3oc(C=Cc4ccc(N(c5ccccc5)c5ccc(C)cc5)cc4)nc3c2)cc1
InChIInChI=1S/C41H28N2O.C37H31NO2.C35H28N2O.C33H24N2O.2C11H11NO/c1-3-11-30(12-4-1)31-22-25-40-38(27-31)42-41(44-40)26-21-29-19-23-34(24-20-29)43(33-14-5-2-6-15-33)39-28-32-13-7-8-16-35(32)36-17-9-10-18-37(36)39;1-24-5-7-27(8-6-24)28-9-11-29(12-10-28)30-13-15-31(16-14-30)33-17-19-34-36(23-33)40-37(38-34)20-18-32-22-35(39-4)26(3)21-25(32)2;1-25-8-15-28(16-9-25)29-17-22-34-33(24-29)36-35(38-34)23-14-27-12-20-32(21-13-27)37(30-6-4-3-5-7-30)31-18-10-26(2)11-19-31;1-4-10-26(11-5-1)27-19-22-31-32(24-27)36-33(34-31)23-18-25-16-20-30(21-17-25)35(28-12-6-2-7-13-28)29-14-8-3-9-15-29;2*1-3-4-11-12-9-7-8(2)5-6-10(9)13-11/h1-28H;5-23H,1-4H3;3-24H,1-2H3;1-24H;2*3-7H,1-2H3/b;20-18+;;;;
InChIKeyALFDSVMHGBDNDT-ZVNWCLRYSA-N
MW2389.97 g/mol
LogP46.60
Rot. Bonds26

About N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine

N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine (PubChem CID 157150600) has the molecular formula C168H133N9O7 and a molecular weight of 2389.97 g/mol. Its IUPAC name is N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine.

Molecular Properties

Compound NameN,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine
PubChem CID157150600
Molecular FormulaC168H133N9O7
Molecular Weight2389.97 g/mol
Exact Mass2388.03
IUPAC NameN,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine
SMILESC(=Cc1nc2cc(-c3ccccc3)ccc2o1)c1ccc(N(c2ccccc2)c2cc3ccccc3c3ccccc23)cc1.C(=Cc1nc2ccc(-c3ccccc3)cc2o1)c1ccc(N(c2ccccc2)c2ccccc2)cc1.CC=Cc1nc2cc(C)ccc2o1.CC=Cc1nc2cc(C)ccc2o1.COc1cc(/C=C/c2nc3ccc(-c4ccc(-c5ccc(-c6ccc(C)cc6)cc5)cc4)cc3o2)c(C)cc1C.Cc1ccc(-c2ccc3oc(C=Cc4ccc(N(c5ccccc5)c5ccc(C)cc5)cc4)nc3c2)cc1
InChIInChI=1S/C41H28N2O.C37H31NO2.C35H28N2O.C33H24N2O.2C11H11NO/c1-3-11-30(12-4-1)31-22-25-40-38(27-31)42-41(44-40)26-21-29-19-23-34(24-20-29)43(33-14-5-2-6-15-33)39-28-32-13-7-8-16-35(32)36-17-9-10-18-37(36)39;1-24-5-7-27(8-6-24)28-9-11-29(12-10-28)30-13-15-31(16-14-30)33-17-19-34-36(23-33)40-37(38-34)20-18-32-22-35(39-4)26(3)21-25(32)2;1-25-8-15-28(16-9-25)29-17-22-34-33(24-29)36-35(38-34)23-14-27-12-20-32(21-13-27)37(30-6-4-3-5-7-30)31-18-10-26(2)11-19-31;1-4-10-26(11-5-1)27-19-22-31-32(24-27)36-33(34-31)23-18-25-16-20-30(21-17-25)35(28-12-6-2-7-13-28)29-14-8-3-9-15-29;2*1-3-4-11-12-9-7-8(2)5-6-10(9)13-11/h1-28H;5-23H,1-4H3;3-24H,1-2H3;1-24H;2*3-7H,1-2H3/b;20-18+;;;;
InChIKeyALFDSVMHGBDNDT-ZVNWCLRYSA-N
XLogP46.60
TPSA175.13 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds26
Heavy Atoms184
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002389.97
LogP ≤ 546.60
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Fluorescent brightener 367
CID 78769
3-methoxy-N-[2-methyl-3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]naphthalene-2-carboxamide
CID 2263244
N-[3-(5,6-dimethyl-1,3-benzoxazol-2-yl)phenyl]-3-methoxynaphthalene-2-carboxamide
CID 15991081
N-[5-(1,3-benzoxazol-2-yl)-2-methylphenyl]-3-methoxynaphthalene-2-carboxamide
CID 1002986
N-[3-(5,6-dimethyl-1,3-benzoxazol-2-yl)-2-methylphenyl]-3-methoxynaphthalene-2-carboxamide
CID 1930733
(1S,3aR,4S,6S)-9-(2-methoxyphenyl)-1,4,7-trimethyl-6-(2-methylprop-1-enyl)-2,3,3a,4,5,6-hexahydro-1H-phenaleno[2,1-d][1,3]oxazole
CID 56602073
(1S,3aR,4S,6S)-9-benzyl-1,4,7-trimethyl-6-(2-methylprop-1-enyl)-2,3,3a,4,5,6-hexahydro-1H-phenaleno[2,1-d][1,3]oxazole
CID 56602070
(E)-1,2-bis(4-(5-(2,4,4-trimethylpentan-2-yl)benzo[d]oxazol-2-yl)phenyl)ethene
CID 107594
2,2'-(Vinylenedi-p-phenylene)bis[5-tert-butylbenzoxazole]
CID 6436902
Phenanthro[9,10-d]oxazole, 2-phenyl-
CID 626439
5-Benzoxazoleethanol, beta-methyl-2-phenyl-, hydrate (4:1)
CID 46400
(1S,3aR,4S,6S)-9-(4-fluorophenyl)-1,4,7-trimethyl-6-(2-methylprop-1-enyl)-2,3,3a,4,5,6-hexahydro-1H-phenaleno[2,1-d][1,3]oxazole
CID 56602075

Frequently Asked Questions

What is the IUPAC name of N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine?
The IUPAC name of N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine (CID 157150600) is N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine.
What is the SMILES notation for N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine?
The canonical SMILES for N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine is C(=Cc1nc2cc(-c3ccccc3)ccc2o1)c1ccc(N(c2ccccc2)c2cc3ccccc3c3ccccc23)cc1.C(=Cc1nc2ccc(-c3ccccc3)cc2o1)c1ccc(N(c2ccccc2)c2ccccc2)cc1.CC=Cc1nc2cc(C)ccc2o1.CC=Cc1nc2cc(C)ccc2o1.COc1cc(/C=C/c2nc3ccc(-c4ccc(-c5ccc(-c6ccc(C)cc6)cc5)cc4)cc3o2)c(C)cc1C.Cc1ccc(-c2ccc3oc(C=Cc4ccc(N(c5ccccc5)c5ccc(C)cc5)cc4)nc3c2)cc1.
What is the InChIKey of N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine?
The InChIKey is ALFDSVMHGBDNDT-ZVNWCLRYSA-N. The full InChI is InChI=1S/C41H28N2O.C37H31NO2.C35H28N2O.C33H24N2O.2C11H11NO/c1-3-11-30(12-4-1)31-22-25-40-38(27-31)42-41(44-40)26-21-29-19-23-34(24-20-29)43(33-14-5-2-6-15-33)39-28-32-13-7-8-16-35(32)36-17-9-10-18-37(36)39;1-24-5-7-27(8-6-24)28-9-11-29(12-10-28)30-13-15-31(16-14-30)33-17-19-34-36(23-33)40-37(38-34)20-18-32-22-35(39-4)26(3)21-25(32)2;1-25-8-15-28(16-9-25)29-17-22-34-33(24-29)36-35(38-34)23-14-27-12-20-32(21-13-27)37(30-6-4-3-5-7-30)31-18-10-26(2)11-19-31;1-4-10-26(11-5-1)27-19-22-31-32(24-27)36-33(34-31)23-18-25-16-20-30(21-17-25)35(28-12-6-2-7-13-28)29-14-8-3-9-15-29;2*1-3-4-11-12-9-7-8(2)5-6-10(9)13-11/h1-28H;5-23H,1-4H3;3-24H,1-2H3;1-24H;2*3-7H,1-2H3/b;20-18+;;;;.
What are the key properties of N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine?
N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine has a molecular weight of 2389.97 g/mol, XLogP of 46.60, 26 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-diphenyl-4-[2-(6-phenyl-1,3-benzoxazol-2-yl)ethenyl]aniline;2-[(E)-2-(5-methoxy-2,4-dimethylphenyl)ethenyl]-6-[4-[4-(4-methylphenyl)phenyl]phenyl]-1,3-benzoxazole;4-methyl-N-[4-[2-[5-(4-methylphenyl)-1,3-benzoxazol-2-yl]ethenyl]phenyl]-N-phenylaniline;bis(5-methyl-2-prop-1-enyl-1,3-benzoxazole);N-phenyl-N-[4-[2-(5-phenyl-1,3-benzoxazol-2-yl)ethenyl]phenyl]phenanthren-9-amine is sourced from PubChem (CID 157150600), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).